Literature DB >> 15616599

Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation.

M Sakai1, M Nishikawa, O Thanaketpaisarn, F Yamashita, M Hashida.   

Abstract

To increase transgene expression in the liver, electric pulses were applied to the left lateral lobe after intravenous injection of naked plasmid DNA (pDNA) or pDNA/liver targeting vector complex prepared with galactosylated poly(L-lysine) or galactosylated polyethyleneimine. Electroporation (250 V/cm, 5 ms/pulse, 12 pulses, 4 Hz) after naked pDNA injection dramatically increased the expression up to 200,000-fold; the expression level obtained was significantly greater than that achieved by the combination of pDNA/vector complex and electroporation. We clearly demonstrated that the expression was dependent on the plasma concentration of pDNA at the time when the electric pulses were applied. Separation of liver cells revealed that the distribution of naked pDNA as well as transgene expression was largely selective to hepatocytes in the electroporated lobe. The number of cells expressing transgene product using vascularly administered naked pDNA followed by electroporation was significantly (P<0.01) greater and more widespread than that obtained by local injection of naked pDNA. These results indicate that the application of in vivo electroporation to vascularly administered naked pDNA is a useful gene transfer approach to a large number of hepatocytes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616599     DOI: 10.1038/sj.gt.3302435

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  8 in total

1.  Tissue-specific characteristics of in vivo electric gene: transfer by tissue and intravenous injection of plasmid DNA.

Authors:  Oranuch Thanaketpaisarn; Makiya Nishikawa; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Pharm Res       Date:  2005-06-08       Impact factor: 4.200

Review 2.  Nonviral gene delivery: what we know and what is next.

Authors:  Xiang Gao; Keun-Sik Kim; Dexi Liu
Journal:  AAPS J       Date:  2007-03-23       Impact factor: 4.009

Review 3.  Nonviral gene delivery: principle, limitations, and recent progress.

Authors:  Mohammed S Al-Dosari; Xiang Gao
Journal:  AAPS J       Date:  2009-10-16       Impact factor: 4.009

Review 4.  Efficacy and safety of Sleeping Beauty transposon-mediated gene transfer in preclinical animal studies.

Authors:  Perry B Hackett; Elena L Aronovich; David Hunter; Myra Urness; Jason B Bell; Steven J Kass; Laurence J N Cooper; Scott McIvor
Journal:  Curr Gene Ther       Date:  2011-10       Impact factor: 4.391

Review 5.  Nonviral vectors: we have come a long way.

Authors:  Tyler Goodwin; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

6.  Discovery of metabolically stabilized electronegative polyacridine-PEG peptide DNA open polyplexes.

Authors:  Christian A Fernandez; Nicholas J Baumhover; Kevin Anderson; Kevin G Rice
Journal:  Bioconjug Chem       Date:  2010-04-21       Impact factor: 4.774

Review 7.  CRISPR somatic genome engineering and cancer modeling in the mouse pancreas and liver.

Authors:  Thorsten Kaltenbacher; Jessica Löprich; Roman Maresch; Julia Weber; Sebastian Müller; Rupert Oellinger; Nina Groß; Joscha Griger; Niklas de Andrade Krätzig; Petros Avramopoulos; Deepak Ramanujam; Sabine Brummer; Sebastian A Widholz; Stefanie Bärthel; Chiara Falcomatà; Anja Pfaus; Ahmed Alnatsha; Julia Mayerle; Marc Schmidt-Supprian; Maximilian Reichert; Günter Schneider; Ursula Ehmer; Christian J Braun; Dieter Saur; Stefan Engelhardt; Roland Rad
Journal:  Nat Protoc       Date:  2022-03-14       Impact factor: 17.021

Review 8.  Physical approaches for nucleic acid delivery to liver.

Authors:  Kenya Kamimura; Dexi Liu
Journal:  AAPS J       Date:  2008-12-13       Impact factor: 4.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.